Stroke in China: advances and challenges in epidemiology, prevention, and management

2019 The Lancet Neurology 1,485 citations

Abstract

With over 2 million new cases annually, stroke is associated with the highest disability-adjusted life-years lost of any disease in China. The burden is expected to increase further as a result of population ageing, an ongoing high prevalence of risk factors (eg, hypertension), and inadequate management. Despite improved access to overall health services, the availability of specialist stroke care is variable across the country, and especially uneven in rural areas. In-hospital outcomes have improved because of a greater availability of reperfusion therapies and supportive care, but adherence to secondary prevention strategies and long-term care are inadequate. Thrombolysis and stroke units are accepted as standards of care across the world, including in China, but bleeding-risk concerns and organisational challenges hamper widespread adoption of this care in China. Despite little supporting evidence, Chinese herbal products and neuroprotective drugs are widely used, and the increased availability of neuroimaging techniques also results in overdiagnosis and overtreatment of so-called silent stroke. Future efforts should focus on providing more balanced availability of specialised stroke services across the country, enhancing evidence-based practice, and encouraging greater translational research to improve outcome of patients with stroke.

Keywords

EpidemiologyChinaStroke (engine)MedicineGeographyEngineeringInternal medicine

MeSH Terms

ChinaDisease ManagementHumansPrevalenceQuality-Adjusted Life YearsStroke

Affiliated Institutions

Related Publications

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Background and Purpose— The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations in a single document for clinicians caring for adult pat...

2019 Stroke 6607 citations

Publication Info

Year
2019
Type
review
Volume
18
Issue
4
Pages
394-405
Citations
1485
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1485
OpenAlex
96
Influential
1282
CrossRef

Cite This

Simiao Wu, Bo Wu, Ming Liu et al. (2019). Stroke in China: advances and challenges in epidemiology, prevention, and management. The Lancet Neurology , 18 (4) , 394-405. https://doi.org/10.1016/s1474-4422(18)30500-3

Identifiers

DOI
10.1016/s1474-4422(18)30500-3
PMID
30878104

Data Quality

Data completeness: 90%